Background To develop and validate nomograms that can be used to predict outcomes in
individuals suffering alpha‐fetoprotein (AFP) negative hepatocellular carcinoma (HCC) after …

Background Preoperative α-fetoprotein (AFP) level levels may help select patients with
hepatocellular carcinoma (HCC) for surgery. The objective of the current study was to …

Background: Alpha-fetoprotein-negative (< 20 ng/mL) hepatocellular carcinoma (AFP-
NHCC) cannot be easily diagnosed in clinical practice, which may affect early treatment and …

Background There is currently no established model for predicting the recurrence of
hepatocellular carcinoma (HCC) in patients with negative alpha‐fetoprotein (AFP) after …

Background This study aimed to establish a simple prognostic scoring model based on
tumor burden score (TBS) and PIVKA‐II to predict long‐term outcomes of α‐fetoprotein …

Background Alpha-fetoprotein-negative hepatocellular carcinoma (AFP-NHCC)(< 8.78
ng/mL) have special clinicopathologic characteristics and prognosis. The aim of this study …

Background This study aimed to investigate the role of the alpha fetoprotein (AFP) ratio
before and after curative resection in the prognosis of patients with hepatocellular carcinoma …

Background To assess preoperative image tumor characteristics and alpha-fetoprotein
(AFP) levels to predict early recurrence after liver resection (LR) for hepatocellular …

Background Few studies have focused on the prognosis of patients with hepatocellular
carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stage 0‒C in terms of early …

Background Prognoses of patients with hepatocellular carcinoma (HCC) after curative
hepatectomy remain unsatisfactory because of the high incidence of postoperative …